Tenet Healthcare Statistics
Total Valuation
THC has a market cap or net worth of $16.35 billion. The enterprise value is $27.84 billion.
| Market Cap | 16.35B |
| Enterprise Value | 27.84B |
Important Dates
The next estimated earnings date is Tuesday, April 28, 2026, before market open.
| Earnings Date | Apr 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
THC has 86.96 million shares outstanding. The number of shares has decreased by -7.20% in one year.
| Current Share Class | 86.96M |
| Shares Outstanding | 86.96M |
| Shares Change (YoY) | -7.20% |
| Shares Change (QoQ) | -0.78% |
| Owned by Insiders (%) | 1.02% |
| Owned by Institutions (%) | 97.80% |
| Float | 85.97M |
Valuation Ratios
The trailing PE ratio is 12.14 and the forward PE ratio is 10.97. THC's PEG ratio is 1.49.
| PE Ratio | 12.14 |
| Forward PE | 10.97 |
| PS Ratio | 0.77 |
| Forward PS | 0.74 |
| PB Ratio | 3.87 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 6.46 |
| P/OCF Ratio | 4.62 |
| PEG Ratio | 1.49 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.01, with an EV/FCF ratio of 11.00.
| EV / Earnings | 19.78 |
| EV / Sales | 1.31 |
| EV / EBITDA | 6.01 |
| EV / EBIT | 7.38 |
| EV / FCF | 11.00 |
Financial Position
The company has a current ratio of 1.76, with a Debt / Equity ratio of 1.61.
| Current Ratio | 1.76 |
| Quick Ratio | 1.51 |
| Debt / Equity | 1.61 |
| Debt / EBITDA | 2.86 |
| Debt / FCF | 5.70 |
| Interest Coverage | 4.59 |
Financial Efficiency
Return on equity (ROE) is 27.02% and return on invested capital (ROIC) is 16.17%.
| Return on Equity (ROE) | 27.02% |
| Return on Assets (ROA) | 8.04% |
| Return on Invested Capital (ROIC) | 16.17% |
| Return on Capital Employed (ROCE) | 14.96% |
| Weighted Average Cost of Capital (WACC) | 8.64% |
| Revenue Per Employee | $215,253 |
| Profits Per Employee | $14,212 |
| Employee Count | 99,000 |
| Asset Turnover | 0.73 |
| Inventory Turnover | 36.00 |
Taxes
In the past 12 months, THC has paid $433.00 million in taxes.
| Income Tax | 433.00M |
| Effective Tax Rate | 15.46% |
Stock Price Statistics
The stock price has increased by +41.21% in the last 52 weeks. The beta is 1.41, so THC's price volatility has been higher than the market average.
| Beta (5Y) | 1.41 |
| 52-Week Price Change | +41.21% |
| 50-Day Moving Average | 212.93 |
| 200-Day Moving Average | 194.90 |
| Relative Strength Index (RSI) | 27.80 |
| Average Volume (20 Days) | 1,025,936 |
Short Selling Information
The latest short interest is 2.49 million, so 2.86% of the outstanding shares have been sold short.
| Short Interest | 2.49M |
| Short Previous Month | 2.76M |
| Short % of Shares Out | 2.86% |
| Short % of Float | 2.90% |
| Short Ratio (days to cover) | 2.54 |
Income Statement
In the last 12 months, THC had revenue of $21.31 billion and earned $1.41 billion in profits. Earnings per share was $15.49.
| Revenue | 21.31B |
| Gross Profit | 8.82B |
| Operating Income | 3.77B |
| Pretax Income | 2.80B |
| Net Income | 1.41B |
| EBITDA | 4.64B |
| EBIT | 3.77B |
| Earnings Per Share (EPS) | $15.49 |
Balance Sheet
The company has $2.88 billion in cash and $14.43 billion in debt, with a net cash position of -$11.49 billion or -$132.08 per share.
| Cash & Cash Equivalents | 2.88B |
| Total Debt | 14.43B |
| Net Cash | -11.49B |
| Net Cash Per Share | -$132.08 |
| Equity (Book Value) | 8.97B |
| Book Value Per Share | 48.53 |
| Working Capital | 3.39B |
Cash Flow
In the last 12 months, operating cash flow was $3.54 billion and capital expenditures -$1.01 billion, giving a free cash flow of $2.53 billion.
| Operating Cash Flow | 3.54B |
| Capital Expenditures | -1.01B |
| Depreciation & Amortization | 863.00M |
| Net Borrowing | -96.00M |
| Free Cash Flow | 2.53B |
| FCF Per Share | $29.09 |
Margins
Gross margin is 41.37%, with operating and profit margins of 17.70% and 6.60%.
| Gross Margin | 41.37% |
| Operating Margin | 17.70% |
| Pretax Margin | 13.14% |
| Profit Margin | 6.60% |
| EBITDA Margin | 21.75% |
| EBIT Margin | 17.70% |
| FCF Margin | 11.87% |
Dividends & Yields
THC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 7.20% |
| Shareholder Yield | 7.20% |
| Earnings Yield | 8.61% |
| FCF Yield | 15.47% |
Analyst Forecast
The average price target for THC is $237.90, which is 26.54% higher than the current price. The consensus rating is "Buy".
| Price Target | $237.90 |
| Price Target Difference | 26.54% |
| Analyst Consensus | Buy |
| Analyst Count | 21 |
| Revenue Growth Forecast (5Y) | 4.30% |
| EPS Growth Forecast (5Y) | 5.28% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 11, 2012. It was a reverse split with a ratio of 1:4.
| Last Split Date | Oct 11, 2012 |
| Split Type | Reverse |
| Split Ratio | 1:4 |
Scores
THC has an Altman Z-Score of 1.92 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.92 |
| Piotroski F-Score | 7 |